The US FTC secures $12M in penalties from 2 medical device companies for structuring an acquisition to evade HSR pre-merger notification (Edwards Lifesciences / Genesis MedTech / JC Medical)
On 13 July 2026, the US Federal Trade Commission announced that it had secured $12M in civil penalties to settle charges that Edwards Lifesciences Corp. and Genesis MedTech Group Limited deliberately…
Read the full articleYou might also wanna read
FTC and DOJ Secure $12 Million Settlement for HSR Act Violations in Edwards/JC Medical Deal
On July 13, 2026, the U.S. Department of Justice (DOJ), on behalf of the Federal Trade Commission (FTC), announced a proposed settlement wit
A Cautionary Tale: FTC Obtains $12M Settlement for Hart-Scott-Rodino Act Failure to File Violation
The FTC imposed $12 million in penalties against Edwards Lifesciences and Genesis MedTech for structuring a deal to avoid HSR Act filing req
Annual HSR Report- Stable Merger Filings, Rising Share of Billion-Dollar Deals
The Federal Trade Commission (FTC) and the Antitrust Division of the U.S. Department of Justice (DOJ) recently issued the 48th annual report
Medical Device Industry Payments to Healthcare Professionals and Organizations in Japan: An Evaluation of Scale, Distribution, and Transparency Practices, 2019-2022
Background Financial relationships between the medical device industry and healthcare providers have raised concerns about conflicts of inte
DOJ Prioritizes Antitrust Enforcement Against Large Health Systems for Payor Contracting Practices
In what is now a trend, on March 26, 2026, the United States Department of Justice Antitrust Division (DOJ) filed an antitrust lawsuit again
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Settlement will drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly The Feder
Comments
Sign in to join the conversation.
No comments yet. Be the first.